
At Melatech, we are committed to making a difference in healthcare by providing solutions that support healthcare professionals and improve patients’ treatment through optimized clinical workflows. We aim to create powerful synergistic effects between doctors and machines through a combination of domain knowledge, engineering, and design. Over a thousand clinicians are currently using our solutions to improve their proficiency and provide optimal skin cancer diagnostics for many thousand patients. Our goal is to help clinicians from all over the world reach their absolute capacity, ensuring the best possible treatment for patients across the globe.

At Melatech, we are committed to making a difference in healthcare by providing solutions that support healthcare professionals and improve patients’ treatment through optimized clinical workflows. We aim to create powerful synergistic effects between doctors and machines through a combination of domain knowledge, engineering, and design. Over a thousand clinicians are currently using our solutions to improve their proficiency and provide optimal skin cancer diagnostics for many thousand patients. Our goal is to help clinicians from all over the world reach their absolute capacity, ensuring the best possible treatment for patients across the globe.
Headquarters: Valby / Copenhagen, Denmark
Founded: 2018
Core product: Dermloop teledermatology platform
Hardware: Dermkit digital dermoscope
Employees: 27
Reported funding (late 2022): ≈ $450k–$574k (seed / pre-seed)
Clinical dermatology workflows and skin-cancer diagnostics
2018
Healthtech / Medical devices & software
≈ €450,000
Reported seed/pre-seed round in late 2022; various public profiles report total raised in the range of ~€450k / $450k–$574k and a valuation reported in DKK.
“Accelerace; individual investors reported (including Nicolaj Højer Nielsen)”